Skip to Content

431 Results Found

  • Article
  • Open Access
30 Citations
4,838 Views
18 Pages

13 August 2021

Muscle wasting and cachexia are prominent comorbidities in cancer. Treatment with polyphenolic compounds may partly revert muscle wasting. We hypothesized that treatment with curcumin or resveratrol in cancer cachectic mice may improve muscle phenoty...

(This article belongs to the Special Issue Recent Progress in Health Benefits from Curcumin)
  • Article
  • Open Access
10 Citations
4,995 Views
30 Pages

Prolonged Immobilization Exacerbates the Loss of Muscle Mass and Function Induced by Cancer-Associated Cachexia through Enhanced Proteolysis in Mice

  • Laura Mañas-García,
  • Antonio Penedo-Vázquez,
  • Adrián López-Postigo,
  • Jorieke Deschrevel and ,
  • Xavier Durán and
  • Esther Barreiro
  • + 1 author+ 0 author

31 October 2020

We hypothesized that in mice with lung cancer (LC)-induced cachexia, periods of immobilization of the hindlimb (7 and 15 days) may further aggravate the process of muscle mass loss and function. Mice were divided into seven groups (n = 10/group): (1)...

(This article belongs to the Special Issue Muscle Atrophy: Discovery of Mechanisms and Potential Therapies)
  • Article
  • Open Access
5 Citations
3,585 Views
20 Pages

11 June 2022

Overactivation of poly (ADPribose) polymerases (PARPs) is involved in cancer-induced cachexia. We hypothesized that the PARP inhibitor rucaparib may improve muscle mass and reduce damage in cancer cachexia mice. In mouse diaphragm and gastrocnemius (...

(This article belongs to the Special Issue PARP Enzymes, ADP-Ribose and NAD+ Metabolism in Cancer)
  • Article
  • Open Access
11 Citations
6,184 Views
24 Pages

Mathematical Model of Muscle Wasting in Cancer Cachexia

  • Suzan Farhang-Sardroodi and
  • Kathleen P. Wilkie

28 June 2020

Cancer cachexia is a debilitating condition characterized by an extreme loss of skeletal muscle mass, which negatively impacts patients’ quality of life, reduces their ability to sustain anti-cancer therapies, and increases the risk of mortalit...

(This article belongs to the Special Issue Latest Developments in Mathematical Oncology and Cancer Systems Biology)
  • Feature Paper
  • Review
  • Open Access
41 Citations
15,084 Views
40 Pages

Nutraceuticals and Exercise against Muscle Wasting during Cancer Cachexia

  • Giorgio Aquila,
  • Andrea David Re Cecconi,
  • Jeffrey J. Brault,
  • Oscar Corli and
  • Rosanna Piccirillo

24 November 2020

Cancer cachexia (CC) is a debilitating multifactorial syndrome, involving progressive deterioration and functional impairment of skeletal muscles. It affects about 80% of patients with advanced cancer and causes premature death. No causal therapy is...

(This article belongs to the Special Issue Skeletal Muscle Atrophy: Mechanisms at a Cellular Level)
  • Review
  • Open Access
20 Citations
7,127 Views
21 Pages

Emerging Mechanisms of Skeletal Muscle Homeostasis and Cachexia: The SUMO Perspective

  • Bushra Khan,
  • Luis Vincens Gand,
  • Mamta Amrute-Nayak and
  • Arnab Nayak

17 February 2023

Mobility is an intrinsic feature of the animal kingdom that stimulates evolutionary processes and determines the biological success of animals. Skeletal muscle is the primary driver of voluntary movements. Besides, skeletal muscles have an immense im...

(This article belongs to the Collection Molecular Mechanisms and Current Treatment Strategy of Sarcopenia and Cachexia)
  • Review
  • Open Access
66 Citations
10,686 Views
18 Pages

Mitochondrial Dysfunction in Cancer Cachexia: Impact on Muscle Health and Regeneration

  • Marc Beltrà,
  • Fabrizio Pin,
  • Riccardo Ballarò,
  • Paola Costelli and
  • Fabio Penna

12 November 2021

Cancer cachexia is a frequently neglected debilitating syndrome that, beyond representing a primary cause of death and cancer therapy failure, negatively impacts on patients’ quality of life. Given the complexity of its multisystemic pathogenesis, af...

(This article belongs to the Section Intracellular and Plasma Membranes)
  • Article
  • Open Access
11 Citations
6,230 Views
23 Pages

Apelin Resistance Contributes to Muscle Loss during Cancer Cachexia in Mice

  • Andrea David Re Cecconi,
  • Mara Barone,
  • Mara Forti,
  • Martina Lunardi and ,
  • Alfredo Cagnotto,
  • Mario Salmona,
  • Davide Olivari,
  • Lorena Zentilin,
  • Andrea Resovi and
  • Rosanna Piccirillo
  • + 10 authors+ 5 authors

2 April 2022

Cancer cachexia consists of dramatic body weight loss with rapid muscle depletion due to imbalanced protein homeostasis. We found that the mRNA levels of apelin decrease in muscles from cachectic hepatoma-bearing rats and three mouse models of cachex...

(This article belongs to the Special Issue Cancer-Associated Cachexia)
  • Review
  • Open Access
5 Citations
3,106 Views
25 Pages

The Role of Non-Coding RNAs in Regulating Cachexia Muscle Atrophy

  • Guoming Chen,
  • Jiayi Zou,
  • Qianhua He,
  • Shuyi Xia and ,
  • Qili Xiao,
  • Ruoxi Du,
  • Shengmei Zhou,
  • Cheng Zhang,
  • Ning Wang and
  • Yibin Feng
  • + 5 authors+ 0 author

27 September 2024

Cachexia is a late consequence of various diseases that is characterized by systemic muscle loss, with or without fat loss, leading to significant mortality. Multiple signaling pathways and molecules that increase catabolism, decrease anabolism, and...

  • Review
  • Open Access
11 Citations
4,479 Views
10 Pages

The Role of Skeletal Muscle Mitochondria in Colorectal Cancer Related Cachexia: Friends or Foes?

  • Britt van de Haterd,
  • Kenneth Verboven,
  • Frank Vandenabeele and
  • Anouk Agten

27 November 2022

Up to 60% of colorectal cancer (CRC) patients develop cachexia. The presence of CRC related cachexia is associated with more adverse events during systemic therapy, leading to a high mortality rate. The main manifestation in CRC related cachexia is t...

(This article belongs to the Special Issue Muscle Atrophy: From Bench to Bedside)
  • Review
  • Open Access
29 Citations
6,492 Views
15 Pages

Impact of Cancer Cachexia on Cardiac and Skeletal Muscle: Role of Exercise Training

  • Cláudia Bordignon,
  • Bethânia S. dos Santos and
  • Daniela D. Rosa

11 January 2022

Cachexia is a multifactorial syndrome that presents with, among other characteristics, progressive loss of muscle mass and anti-cardiac remodeling effect that may lead to heart failure. This condition affects about 80% of patients with advanced cance...

(This article belongs to the Section Cancer Pathophysiology)
  • Article
  • Open Access
14 Citations
3,683 Views
18 Pages

BNIP3 Downregulation Ameliorates Muscle Atrophy in Cancer Cachexia

  • Claudia Fornelli,
  • Marc Beltrà,
  • Antonio Zorzano,
  • Paola Costelli and ,
  • David Sebastian and
  • Fabio Penna
  • + 1 author+ 0 author

11 December 2024

Background and Aims: Cancer cachexia is a complex syndrome affecting most cancer patients and is directly responsible for about 20% of cancer-related deaths. Previous studies showed muscle proteolysis hyper-activation and mitophagy induction in tumor...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
102 Citations
8,838 Views
17 Pages

Human Cachexia Induces Changes in Mitochondria, Autophagy and Apoptosis in the Skeletal Muscle

  • Gabriela S. de Castro,
  • Estefania Simoes,
  • Joanna D.C.C. Lima,
  • Milene Ortiz-Silva and ,
  • William T. Festuccia,
  • Flávio Tokeshi,
  • Paulo S. Alcântara,
  • José P. Otoch,
  • Dario Coletti and
  • Marilia Seelaender
  • + 5 authors+ 0 author

28 August 2019

Cachexia is a wasting syndrome characterized by the continuous loss of skeletal muscle mass due to imbalance between protein synthesis and degradation, which is related with poor prognosis and compromised quality of life. Dysfunctional mitochondria a...

(This article belongs to the Special Issue Cancer Cachexia)
  • Article
  • Open Access
24 Citations
6,725 Views
17 Pages

Lithium Chloride Protects against Sepsis-Induced Skeletal Muscle Atrophy and Cancer Cachexia

  • Ji-Hyung Lee,
  • Seon-Wook Kim,
  • Jun-Hyeong Kim,
  • Hyun-Jun Kim and ,
  • JungIn Um,
  • Da-Woon Jung and
  • Darren R. Williams
  • + 2 authors+ 0 author

26 April 2021

Inflammation-mediated skeletal muscle wasting occurs in patients with sepsis and cancer cachexia. Both conditions severely affect patient morbidity and mortality. Lithium chloride has previously been shown to enhance myogenesis and prevent certain fo...

  • Article
  • Open Access
18 Citations
5,096 Views
23 Pages

Marked Increased Production of Acute Phase Reactants by Skeletal Muscle during Cancer Cachexia

  • Isabelle S. Massart,
  • Geneviève Paulissen,
  • Audrey Loumaye,
  • Pascale Lause and ,
  • Sarah A. Pötgens,
  • Morgane M. Thibaut,
  • Estelle Balan,
  • Louise Deldicque,
  • Azeddine Atfi and
  • Jean-Paul Thissen
  • + 9 authors+ 4 authors

31 October 2020

Loss of skeletal muscle mass in cancer cachexia is recognized as a predictor of mortality. This study aimed to characterize the changes in the muscle secretome associated with cancer cachexia to gain a better understanding of the mechanisms involved...

  • Review
  • Open Access
9 Citations
10,455 Views
10 Pages

Muscular dystrophies (MDs) are inheritable diseases caused by mutations in specific genes encoding muscle proteins and characterized by progressive muscle wasting and weakness. MDs are classified into nine main categories, encompassing approximately...

  • Article
  • Open Access
62 Citations
11,222 Views
27 Pages

Musclin, A Myokine Induced by Aerobic Exercise, Retards Muscle Atrophy During Cancer Cachexia in Mice

  • Andrea D. Re Cecconi,
  • Mara Forti,
  • Michela Chiappa,
  • Zhiyong Zhu and ,
  • Leonid V. Zingman,
  • Luigi Cervo,
  • Luca Beltrame,
  • Sergio Marchini and
  • Rosanna Piccirillo
  • + 4 authors+ 0 author

12 October 2019

Physical activity improves the prognosis of cancer patients, partly by contrasting the associated muscle wasting (cachexia), through still unknown mechanisms. We asked whether aerobic exercise causes secretion by skeletal muscles of proteins (myokine...

(This article belongs to the Special Issue Cancer Cachexia)
  • Article
  • Open Access
23 Citations
6,149 Views
21 Pages

Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1

  • Weili Tao,
  • Ze Ouyang,
  • Zhiqi Liao,
  • Lu Li and ,
  • Yujie Zhang,
  • Jiali Gao,
  • Li Ma and
  • Shiying Yu
  • + 3 authors+ 0 author

20 April 2023

Skeletal muscle wasting is the most remarkable phenotypic feature of cancer cachexia that increases the risk of morbidity and mortality. However, there are currently no effective drugs against cancer cachexia. Ursolic acid (UA) is a lipophilic pentac...

(This article belongs to the Special Issue Advances in Cancer Cachexia)
  • Article
  • Open Access
25 Citations
4,964 Views
16 Pages

Aerobic Exercise Ameliorates Cancer Cachexia-Induced Muscle Wasting through Adiponectin Signaling

  • Makoto Morinaga,
  • Naoki Sako,
  • Mari Isobe,
  • Sachiko Lee-Hotta and ,
  • Hideshi Sugiura and
  • Satoshi Kametaka
  • + 1 author+ 0 author

Cachexia is a multifactorial syndrome characterized by muscle loss that cannot be reversed by conventional nutritional support. To uncover the molecular basis underlying the onset of cancer cachectic muscle wasting and establish an effective interven...

(This article belongs to the Special Issue New Insights on Cell Metabolism)
  • Article
  • Open Access
1,258 Views
18 Pages

Phloretin Attenuates Cancer Cachexia-Induced Skeletal Muscle Wasting Associated with the Modulation of STAT3 Signaling

  • Kai Lin,
  • Mei-Wei He,
  • Fei Wang,
  • Xin-Yu Hu and ,
  • Zi-Yue He,
  • Chen-Lu Zhang,
  • Zhi-Qiang Huang and
  • Hong-Wei Wang
  • + 3 authors+ 0 author

Background/Objectives: Cancer cachexia (CC) is a metabolic syndrome characterized by the progressive loss of skeletal muscle and adipose tissue during tumor progression. Despite its clinical prevalence, effective therapeutic options are currently lac...

(This article belongs to the Section Cancer Biology and Oncology)
  • Article
  • Open Access
26 Citations
5,874 Views
14 Pages

Deterioration in Muscle Mass and Physical Function Differs According to Weight Loss History in Cancer Cachexia

  • Guro Birgitte Stene,
  • Trude Rakel Balstad,
  • Anne Silja M. Leer,
  • Asta Bye and ,
  • Stein Kaasa,
  • Marie Fallon,
  • Barry Laird,
  • Matthew Maddocks and
  • Tora S. Solheim
  • + 4 authors+ 0 author

3 December 2019

Background: Muscle mass and physical function (PF) are common co-primary endpoints in cancer cachexia trials, but there is a lack of data on how these outcomes interact over time. The aim of this secondary analysis of data from a trial investigating...

(This article belongs to the Special Issue Cancer Cachexia)
  • Article
  • Open Access
26 Citations
6,681 Views
23 Pages

Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways

  • Ashok Narasimhan,
  • Xiaoling Zhong,
  • Ernie P. Au,
  • Eugene P. Ceppa and ,
  • Atilla Nakeeb,
  • Michael G. House,
  • Nicholas J. Zyromski,
  • C. Max Schmidt,
  • Katheryn N. H. Schloss and
  • Teresa A. Zimmers
  • + 14 authors+ 9 authors

20 April 2021

The vast majority of patients with pancreatic ductal adenocarcinoma (PDAC) suffer cachexia. Although cachexia results from concurrent loss of adipose and muscle tissue, most studies focus on muscle alone. Emerging data demonstrate the prognostic valu...

  • Article
  • Open Access
4 Citations
2,399 Views
15 Pages

8 February 2025

Cachexia is a multifactorial syndrome characterized by severe muscle wasting and is a debilitating condition frequently associated with cancer. Previous studies from our group revealed that withaferin A (WFA), a steroidal lactone, mitigated muscle ca...

(This article belongs to the Section Cells of the Cardiovascular System)
  • Article
  • Open Access
4 Citations
3,242 Views
16 Pages

The Protective Effects of Perch Essence Against Muscle Atrophy in Cancer Cachexia and Cisplatin Treatment

  • Shu-Lan Yeh,
  • Pei-Yin Chen,
  • Jiunn-Wang Liao,
  • Ruo-Li Huang and ,
  • Shu-Han Yu,
  • Ling-Ni Chen,
  • Mao-Hsiang Lee,
  • Li-Wen Chen,
  • Haw-Wen Chen and
  • Kai-Li Liu
  • + 7 authors+ 2 authors

Muscle atrophy, through several pathways including increased protein catabolism, leads to adverse effects in cachexia induced by cancer and chemotherapy. Perch essence (PE) is a perch extract rich in branched-chain amino acids and peptides. The prese...

(This article belongs to the Special Issue Innovations in Marine Biotechnology and Molecular Biology)
  • Review
  • Open Access
15 Citations
5,014 Views
17 Pages

9 November 2023

Cancer-associated cachexia is a metabolic syndrome that causes significant reduction in whole-body weight due to excessive loss of muscle mass accompanied by loss of fat mass. Reduced food intake and several metabolic abnormalities, such as increased...

(This article belongs to the Special Issue Extracellular Vesicles in Health and Disease 2023)
  • Article
  • Open Access
16 Citations
4,254 Views
17 Pages

Physiactisome: A New Nanovesicle Drug Containing Heat Shock Protein 60 for Treating Muscle Wasting and Cachexia

  • Valentina Di Felice,
  • Rosario Barone,
  • Eleonora Trovato,
  • Daniela D’Amico and ,
  • Filippo Macaluso,
  • Claudia Campanella,
  • Antonella Marino Gammazza,
  • Vera Muccilli,
  • Vincenzo Cunsolo and
  • Francesco Cappello
  • + 10 authors+ 5 authors

21 April 2022

Currently, no commercially available drugs have the ability to reverse cachexia or counteract muscle wasting and the loss of lean mass. Here, we report the methodology used to develop Physiactisome—a conditioned medium released by heat shock pr...

(This article belongs to the Section Cellular Metabolism)
  • Review
  • Open Access

Emerging Therapeutic Strategies Targeting Muscle Wasting in Parkinson’s Disease: From Sarcopenia to Cachexia-like Syndrome

  • Emilia Manole,
  • Gisela Gaina,
  • Elena Mihaela Dragnea,
  • Laura Cristina Ceafalan and
  • Bogdan Ovidiu Popescu

17 November 2026

Clinically relevant muscle wasting affects a substantial proportion of patients with Parkinson’s disease (PD), although its prevalence varies according to the diagnostic criteria applied. This condition accelerates disease progression, reduces...

(This article belongs to the Special Issue Cellular and Molecular Mechanisms Underlying Neuromuscular System Disorders)
  • Article
  • Open Access
30 Citations
7,675 Views
16 Pages

Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia

  • Brandon N. VanderVeen,
  • Thomas D. Cardaci,
  • Patrice Cunningham,
  • Sierra J. McDonald and ,
  • Brooke M. Bullard,
  • Daping Fan,
  • E. Angela Murphy and
  • Kandy T. Velázquez
  • + 3 authors+ 0 author

25 December 2022

A cachexia diagnosis is associated with a doubling in hospital stay and increased healthcare cost for cancer patients and most cachectic patients do not survive treatment. Unfortunately, complexity in treating cachexia is amplified by both the underl...

(This article belongs to the Section Phytochemicals and Human Health)
  • Protocol
  • Open Access
693 Views
18 Pages

Assessment of Muscle Function Decline and Cachexia-Related Biomarkers in Hospitalized Oncology Patients: Study Protocol

  • Jorge Juan Alvarado-Omenat,
  • Emilio Fonseca-Sánchez,
  • Rocío Llamas-Ramos,
  • Daniel García-García and ,
  • Marta Correyero-León and
  • Inés Llamas-Ramos
  • + 1 author+ 0 author

Background: Cancer cachexia and sarcopenia are highly prevalent complications affecting up to 50% of patients with cancer and are associated with increased treatment toxicity, poorer functional outcomes, and reduced survival. Early identification of...

(This article belongs to the Special Issue Emerging Trends in Cancer: Biomarkers, Therapeutic Strategies and Future Directions)
  • Article
  • Open Access
885 Views
26 Pages

The Secretome of a Cachexia-Inducing Lung Tumor Impairs Mitochondrial Function and Skeletal Muscle Differentiation

  • Nikki Wanders,
  • Marvin Martens,
  • Marco Kelders,
  • Sven Manse and ,
  • Sandra van Krimpen,
  • Claire Groenen,
  • Chrysi Kapsali,
  • Paula Bilbao Fraile,
  • Konstantina Bermperi and
  • Ramon Langen
  • + 10 authors+ 5 authors

30 June 2026

Background: Cancer-associated cachexia (CAC) can affect up to 80% of patients with late-stage cancer and is characterized by depletion of skeletal muscle mass with or without loss of fat tissue. No effective treatments are currently available, and re...

(This article belongs to the Section Molecular Cancer Biology)
  • Article
  • Open Access
18 Citations
4,920 Views
18 Pages

4 December 2022

Cachexia associated with chronic kidney disease (CKD) has been linked to GH resistance. In CKD, GH treatment enhances muscular performance. We investigated the impact of GH on cachexia brought on by CKD. CKD was induced by 5/6 nephrectomy in c57BL/6J...

(This article belongs to the Special Issue Chronic Kidney Disease: Underlying Molecular Mechanisms)
  • Article
  • Open Access
21 Citations
6,452 Views
25 Pages

Leucine-Rich Diet Modulates the Metabolomic and Proteomic Profile of Skeletal Muscle during Cancer Cachexia

  • Bread Cruz,
  • André Oliveira,
  • Lais Rosa Viana,
  • Leisa Lopes-Aguiar and ,
  • Rafael Canevarolo,
  • Maiara Caroline Colombera,
  • Rafael Rossi Valentim,
  • Fernanda Garcia-Fóssa,
  • Lizandra Maia de Sousa and
  • Maria Cristina Cintra Gomes-Mardondes
  • + 10 authors+ 5 authors

13 July 2020

Background: Cancer-cachexia induces a variety of metabolic disorders, including skeletal muscle imbalance. Alternative therapy, as nutritional supplementation with leucine, shows a modulatory effect over tumour damage in vivo and in vitro. Method: Ad...

(This article belongs to the Special Issue The Cancer Proteome)
  • Article
  • Open Access
13 Citations
6,145 Views
15 Pages

MRI-Determined Psoas Muscle Fat Infiltration Correlates with Severity of Weight Loss during Cancer Cachexia

  • Lisa Patzelt,
  • Daniela Junker,
  • Jan Syväri,
  • Egon Burian and ,
  • Mingming Wu,
  • Olga Prokopchuk,
  • Ulrich Nitsche,
  • Marcus R. Makowski,
  • Rickmer F. Braren and
  • Dimitrios C. Karampinos
  • + 7 authors+ 2 authors

2 September 2021

Purpose: To evaluate the suitability of psoas and erector spinae muscle proton density fat fraction (PDFF) and fat volume as biomarkers for monitoring cachexia severity in an oncological cohort, and to evaluate regional variances in muscle parameters...

(This article belongs to the Special Issue Cancer-Associated Cachexia)
  • Article
  • Open Access
19 Citations
6,602 Views
17 Pages

2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle

  • Lulu Wei,
  • Ranran Wang,
  • Junaid Wazir,
  • Kai Lin and ,
  • Shiyu Song,
  • Li Li,
  • Wenyuan Pu,
  • Chen Zhao,
  • Yong Wang and
  • Hongwei Wang
  • + 6 authors+ 1 author

25 September 2022

Cachexia is characterized by progressive weight loss accompanied by the loss of specific skeletal muscle and adipose tissue. Increased lactate production, either due to the Warburg effect from tumors or accelerated glycolysis effects from cachectic m...

  • Article
  • Open Access
1 Citations
2,857 Views
13 Pages

Longitudinal Muscle Biopsies Reveal Inter- and Intra-Subject Variability in Cancer Cachexia: Paving the Way for Biopsy-Guided Tailored Treatment

  • Panagiotis Filis,
  • Nikolaos P. Tzavellas,
  • Dimitrios Stagikas,
  • Christianna Zachariou and ,
  • Panagiotis Lekkas,
  • Dimitrios Kosmas,
  • Evangelia Dounousi,
  • Ioannis Sarmas,
  • Evangelia Ntzani and
  • Dimitrios Peschos
  • + 9 authors+ 4 authors

6 March 2024

In the rapidly evolving landscape of cancer cachexia research, the development and refinement of diagnostic and predictive biomarkers constitute an ongoing challenge. This study aims to introduce longitudinal muscle biopsies as a potential framework...

(This article belongs to the Special Issue Advances in Cancer Cachexia)
  • Review
  • Open Access
7 Citations
4,188 Views
16 Pages

Three Pathways of Cancer Cachexia: Inflammation, Changes in Adipose Tissue and Loss of Muscle Mass—The Role of miRNAs

  • Iwona Homa-Mlak,
  • Dominika Pigoń-Zając,
  • Paweł Wawrejko,
  • Teresa Małecka-Massalska and
  • Radosław Mlak

31 August 2022

According to the World Health Organization, in 2018, cancers, along with over 18 million new cases and over 9.5 million deaths remained one of the main causes of mortality globally. Cancer-cachexia, also called wasting syndrome is a complex, multifac...

(This article belongs to the Special Issue MiRNA Targets in Cancer: Diagnosis, Prognosis and Treatment)
  • Article
  • Open Access
11 Citations
5,549 Views
20 Pages

Metronomic 5-Fluorouracil Delivery Primes Skeletal Muscle for Myopathy but Does Not Cause Cachexia

  • Dean G. Campelj,
  • Cara A. Timpani,
  • Tabitha Cree,
  • Aaron C. Petersen and ,
  • Alan Hayes,
  • Craig A. Goodman and
  • Emma Rybalka
  • + 2 authors+ 0 author

Skeletal myopathy encompasses both atrophy and dysfunction and is a prominent event in cancer and chemotherapy-induced cachexia. Here, we investigate the effects of a chemotherapeutic agent, 5-fluorouracil (5FU), on skeletal muscle mass and function,...

(This article belongs to the Special Issue Cancer Drugs Treatment and Toxicity)
  • Article
  • Open Access
15 Citations
4,728 Views
18 Pages

A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia

  • Alex Gonzalez,
  • Wai W. Cheung,
  • Elliot A. Perens,
  • Eduardo A. Oliveira and ,
  • Arieh Gertler and
  • Robert H. Mak
  • + 1 author+ 0 author

31 July 2021

Mice lacking the functional cystinosin gene (Ctns−/−), a model of infantile nephropathic cystinosis (INC), exhibit the cachexia phenotype with adipose tissue browning and muscle wasting. Elevated leptin signaling is an important cause of chronic kidn...

(This article belongs to the Section Tissues and Organs)
  • Review
  • Open Access
37 Citations
7,484 Views
14 Pages

Cachexia is a multifactorial and multi-organ syndrome that is a major cause of morbidity and mortality in late-stage chronic diseases. The main clinical features of cancer-related cachexia are chronic inflammation, wasting of skeletal muscle and adip...

(This article belongs to the Special Issue Highlights in Pathophysiology of the Musculoskeletal System)
  • Article
  • Open Access
2 Citations
2,980 Views
17 Pages

21 March 2025

Background/Objectives: Cancer cachexia (CC) is a prevalent and debilitating syndrome in cancer patients, characterized by severe muscle and weight loss, leading to increased mortality and reduced quality of life. Despite the significant impact, effec...

(This article belongs to the Section Medicinal Chemistry)
  • Article
  • Open Access
13 Citations
5,753 Views
28 Pages

The Paradoxical Effect of PARP Inhibitor BGP-15 on Irinotecan-Induced Cachexia and Skeletal Muscle Dysfunction

  • Dean G. Campelj,
  • Cara A. Timpani,
  • Aaron C. Petersen,
  • Alan Hayes and ,
  • Craig A. Goodman and
  • Emma Rybalka
  • + 1 author+ 0 author

17 December 2020

Chemotherapy-induced muscle wasting and dysfunction is a contributing factor to cachexia alongside cancer and increases the risk of morbidity and mortality. Here, we investigate the effects of the chemotherapeutic agent irinotecan (IRI) on skeletal m...

(This article belongs to the Section Cancer Therapy)
  • Review
  • Open Access
1,879 Views
23 Pages

5 February 2026

Colorectal cancer (CRC) cachexia is a multifactorial, treatment-limiting syndrome characterized by progressive loss of skeletal muscle with or without loss of fat mass, accompanied by systemic inflammation, anorexia, metabolic dysregulation, and impa...

(This article belongs to the Section Cancer Survivorship and Quality of Life)
  • Article
  • Open Access
31 Citations
7,309 Views
17 Pages

Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia

  • Ahmad Rushdi Shakri,
  • Timothy James Zhong,
  • Wanchao Ma,
  • Courtney Coker and ,
  • Sean Kim,
  • Stephanie Calluori,
  • Hanna Scholze,
  • Matthias Szabolcs,
  • Thomas Caffrey and
  • Swarnali Acharyya
  • + 11 authors+ 6 authors

18 December 2019

Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer type in which the mortality rate approaches the incidence rate. More than 85% of PDAC patients experience a profound loss of muscle mass and function, known as cachexia. PDAC patients with th...

(This article belongs to the Special Issue Cancer Cachexia)
  • Review
  • Open Access
52 Citations
8,153 Views
23 Pages

Muscle dysfunction, characterized by a reductive remodeling of muscle fibers, is a common systemic manifestation in highly prevalent conditions such as chronic heart failure (CHF), chronic obstructive pulmonary disease (COPD), cancer cachexia, and cr...

(This article belongs to the Special Issue Striated Muscle Proteomics)
  • Review
  • Open Access
45 Citations
12,285 Views
18 Pages

Cachexia, a Systemic Disease beyond Muscle Atrophy

  • Elisabeth Wyart,
  • Laure B. Bindels,
  • Erica Mina,
  • Alessio Menga and ,
  • Serena Stanga and
  • Paolo E. Porporato
  • + 1 author+ 0 author

14 November 2020

Cachexia is a complication of dismal prognosis, which often represents the last step of several chronic diseases. For this reason, the comprehension of the molecular drivers of such a condition is crucial for the development of management approaches....

(This article belongs to the Special Issue Cancer Cachexia and Related Metabolic Dysfunction)
  • Commentary
  • Open Access
23 Citations
11,072 Views
5 Pages

Cancer Cachexia: Muscle Physiology and Exercise Training

  • Claudio L. Battaglini,
  • Anthony C. Hackney and
  • Matthew L. Goodwin

29 November 2012

Cachexia in cancer patients is a condition marked by severe tissue wasting and a myriad of quality of life and health consequences. Cachexia is also directly linked to the issues of morbidity and survivability in cancer patients. Therapeutic means of...

  • Review
  • Open Access
15 Citations
5,082 Views
21 Pages

Liquid Biopsy for Cancer Cachexia: Focus on Muscle-Derived microRNAs

  • Roberta Belli,
  • Elisabetta Ferraro,
  • Alessio Molfino,
  • Raffaella Carletti and ,
  • Federica Tambaro,
  • Paola Costelli and
  • Maurizio Muscaritoli
  • + 2 authors+ 0 author

20 August 2021

Cancer cachexia displays a complex nature in which systemic inflammation, impaired energy metabolism, loss of muscle and adipose tissues result in unintentional body weight loss. Cachectic patients have a poor prognosis and the presence of cachexia r...

(This article belongs to the Special Issue Novel Molecular Approaches to Skeletal Muscle Disease and Disuse)
  • Commentary
  • Open Access
26 Citations
9,699 Views
6 Pages

Is Cancer Cachexia Attributed to Impairments in Basal or Postprandial Muscle Protein Metabolism?

  • Astrid M. H. Horstman,
  • Steven W. Olde Damink,
  • Annemie M. W. J. Schols and
  • Luc J. C. Van Loon

16 August 2016

Cachexia is a significant clinical problem associated with very poor quality of life, reduced treatment tolerance and outcomes, and a high mortality rate. Mechanistically, any sizeable loss of skeletal muscle mass must be underpinned by a structural...

  • Review
  • Open Access
18 Citations
8,622 Views
18 Pages

31 August 2022

Cancer cachexia (CC) is a multifactorial syndrome characterized by a significant reduction in body weight that is predominantly caused by the loss of skeletal muscle and adipose tissue. Although the ill effects of cachexia are well known, the conditi...

(This article belongs to the Special Issue Phase Separation, Chromatin Organization and Transcription for Cancers)
  • Review
  • Open Access
5 Citations
5,458 Views
16 Pages

From Mouth to Muscle: Exploring the Potential Relationship between the Oral Microbiome and Cancer-Related Cachexia

  • Shreya R. Raman,
  • Christopher Liu,
  • Kelly M. Herremans,
  • Andrea N. Riner and ,
  • Vignesh Vudatha,
  • Devon C. Freudenberger,
  • Kelley L. McKinley,
  • Eric W. Triplett and
  • Jose G. Trevino
  • + 4 authors+ 0 author

Cancer cachexia is a multifactorial wasting syndrome associated with skeletal muscle and adipose tissue loss, as well as decreased appetite. It affects approximately half of all cancer patients and leads to a decrease in treatment efficacy, quality o...

(This article belongs to the Special Issue Tumor-Related Host-Microbiota Interactions)

of 9